SCHEMBL6002638

SCHEMBL6002638

[CH2]C1(c2ccccc2)N=CC(c2ccccc2)=N1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28813678 0.76 ALDH1A1 (0.32) LMNASMN1; SMN2NPY5R
SCHEMBL28811963 0.73 ALDH1A1 (0.33) LMNANPY5R
SCHEMBL3969821 0.66 BACE1 (0.32) LMNA
SCHEMBL23567117 0.58 KMT2A (0.32) LMNANPY5R
SCHEMBL14889308 0.57 ALDH1A1 (0.44) LMNASMN1; SMN2
SCHEMBL491053 0.57 ALDH1A1 (0.39) LMNASMN1; SMN2NPY5R
Biphenyl SCHEMBL6036136 0.57 ALDH1A1 (0.75) LMNASMN1; SMN2
Biphenyl SCHEMBL302887 0.56 ALDH1A1 (0.90) LMNASMN1; SMN2
Biphenyl SCHEMBL164459 0.56 ALDH1A1 (0.90) LMNASMN1; SMN2
Biphenyl SCHEMBL688885 0.56 ALDH1A1 (0.90) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed